This idea is also supported by the finding that there are more PTEN mutations identified in EBV-negative BLs than EBV-positive BLs, although the overall frequency with which PTEN mutations occur in BL is only 4% (Grande et al., 2019). This evidence concerns the gene PTEN and Burkitt lymphoma.